Diagnostics News and Research

RSS

Bruker is to be key International Phenome Centre Network corporate partner for NMR Technologies and SOPs

The International Phenome Centre Network (IPCN), founded by Imperial College London and more than a dozen international partners in Australia, Canada, China, Japan, Singapore, Taiwan, the US, and the UK (www.phenomenetwork.org), was launched officially this week at the 2016 World Innovation Summit for Health (WISH) conference in Doha, Qatar. This global network is a critical link between leading research centers across the world and will support research into some of today’s most pressing global health challenges.

From Bruker 23 Jan 2017

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.

23 Jan 2017

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.

20 Jan 2017

Gestational diabetes raises postpartum depression risk in first-time mothers

Researchers from the Icahn School of Medicine at Mount Sinai and the Karolinska Institutet have found that gestational diabetes raises the risk of postpartum depression (PPD) in first-time mothers.

18 Jan 2017

Improving fungal disease diagnostics could help battle against antimicrobial resistance

Ignorance of fungal disease and lack of diagnostics across the world is causing doctors to unknowingly overprescribe antibiotics a new report warns.

18 Jan 2017

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

A study led by scientists at the Translational Genomics Research Institute has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer.

18 Jan 2017

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Standard chemotherapy is a blunt force instrument against cancer - and it's a rare cancer patient who escapes debilitating side effects from systemic treatments that mostly affect dividing cells, both malignant and healthy, throughout the body.

17 Jan 2017

Metabolomics and NMR

Bruker has been involved in the Phenome Center network since its beginning. Several years ago, the whole visionary concept of a global phenome network was actually born with Professor Jeremy Nicholson and Bruker BioSpin has been part of it since the early stages.

From Bruker BioSpin Group 17 Jan 2017

Better fungal disease diagnostics could be critical to fight against antimicrobial resistance

Poor diagnosis worldwide of fungal disease causes doctors to overprescribe antibiotics, increasing harmful resistance to antimicrobial drugs, according to a paper published today in Emerging Infectious Diseases.

17 Jan 2017

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of research, understanding why cancer cells become invasive has remained shrouded in mystery.

17 Jan 2017

Knowledge bank approach could help find best treatment option for AML patients

An international collaboration led by clinical researchers at the Wellcome Trust Sanger Institute has shown proof-of-concept that truly personalised therapy will be possible in the future for people with cancer.

17 Jan 2017

New pocket guide offers detailed guidance on treating older adults with mental health issues

Nearly 20 percent of older Americans experience depression and the highest rate of suicide is among older adult Caucasian males.

16 Jan 2017

MUSC scientists design novel antibody-based therapy to fight against cancer

Scientists at the Medical University of South Carolina (MUSC) have designed an antibody-based therapy that could target the functions of TGF-beta that cause cancer

12 Jan 2017

Tecan ensures ease of pipetting with Liquid Handling Arm™ disposable tip

Tecan is simplifying handling of biological fluids with the introduction of a wide bore version of its popular 1,000 μl Liquid Handling Arm™ (LiHa) disposable tip.

From Tecan 11 Jan 2017

UT researchers developing cheap, portable device for detecting diabetes at early stage

Researchers at the University of Twente, in cooperation with commercial parties, are developing a portable device for detecting type 1 or type 2 diabetes at an early stage.

10 Jan 2017

Researcher uncovers secret life of Dab2 protein

Sometimes proteins do a lot more than we expect. Dab2, for example, has long been linked to cancer.

10 Jan 2017

Researchers discover how deficiency of IgM antibodies can lead to increased risk of arteriosclerosis

Following a blood infection, the first class of antibodies produced by the immune system are IgM antibodies.

9 Jan 2017

The 10th annual symposium at UC Riverside focuses on glial-neuronal interactions in health and disease

The brain is home to two kinds of cells: neurons and glia, with the latter protecting the former. Glia, the stuff between neurons, are important also because they regulate and define neuron-neuron communication.

9 Jan 2017

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

6 Jan 2017

Researchers develop novel tests that could improve treatment for heart failure patients

For the first time, researchers have developed tests that could improve treatment for heart failure patients by diagnosing the condition with greater accuracy, as well as by detecting the onset of congestive heart failure earlier.

5 Jan 2017

Diagnostics News and Research

Bruker is to be key International Phenome Centre Network corporate partner for NMR Technologies and SOPs

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

Gestational diabetes raises postpartum depression risk in first-time mothers

Improving fungal disease diagnostics could help battle against antimicrobial resistance

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Metabolomics and NMR

Better fungal disease diagnostics could be critical to fight against antimicrobial resistance

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Knowledge bank approach could help find best treatment option for AML patients

New pocket guide offers detailed guidance on treating older adults with mental health issues

MUSC scientists design novel antibody-based therapy to fight against cancer

Tecan ensures ease of pipetting with Liquid Handling Arm™ disposable tip

UT researchers developing cheap, portable device for detecting diabetes at early stage

Researcher uncovers secret life of Dab2 protein

Researchers discover how deficiency of IgM antibodies can lead to increased risk of arteriosclerosis

The 10th annual symposium at UC Riverside focuses on glial-neuronal interactions in health and disease

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Researchers develop novel tests that could improve treatment for heart failure patients

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News